Modulation of Fibrosis After Ahmed Glaucoma Valve Implantation: Comparing Ologen and Anti-VEGF Therapy in Refractory Glaucoma

Authors

  • Noran Mohamed Mansour Hafez, Mohamed Abdelkader Ibrahim, Salah Mohamed Al Sayed Al-Mosallamy, Ahmed Mahmoud Alyan Author

DOI:

https://doi.org/10.48047/16fzxc45

Keywords:

Ahmed Glaucoma Valve Implantation, Ologen , Anti-VEGF Therapy ,Refractory Glaucoma

Abstract

Background: Refractory glaucoma represents a major therapeutic challenge in ophthalmology because of the high risk of progressive optic neuropathy and failure of conventional filtration procedures. Ahmed glaucoma valve (AGV) implantation has become one of the most widely  used surgical options for refractory glaucoma owing to its efficacy in lowering intraocular pressure

Downloads

Download data is not yet available.

References

Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262-267.

Kang YK, Shin JP, Kim DW. Long-term surgical outcomes of Ahmed valve implantation in refractory glaucoma according to the type of glaucoma. BMC Ophthalmol. 2022;22(1):270.

Downloads

Published

2024-11-20

Issue

Vol. 53 No. 03 (2024): Year 2024, Volume 53, Issue 3

Section

Original

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  1. Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
  2. Adapt — remix, transform, and build upon the material for any purpose, even commercially.
  3. The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  1. Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  2. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:

You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .

No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.

How to Cite

Modulation of Fibrosis After Ahmed Glaucoma Valve Implantation: Comparing Ologen and Anti-VEGF Therapy in Refractory Glaucoma (Noran Mohamed Mansour Hafez, Mohamed Abdelkader Ibrahim, Salah Mohamed Al Sayed Al-Mosallamy, Ahmed Mahmoud Alyan , Trans.). (2024). Cuestiones De Fisioterapia, 53(03), 7608-7624. https://doi.org/10.48047/16fzxc45